Large, nonplateauing relationship between clinical disability and cerebral white matter lesion load in patients with multiple sclerosis.

OBJECTIVE To better characterize the relationship between cerebral white matter lesion load (CWM-LL) and clinical disability by (1) covering the entire range of the Kurtzke Expanded Disability Status Scale (EDSS), (2) minimizing nonbiological sources of variability, and (3) increasing pathologic specificity by studying CWM lesions that are hypointense on T1-weighted magnetic resonance imaging. DESIGN Cross-sectional, retrospective study. SETTING Hospital-based multiple sclerosis (MS) clinic. Patients  A total of 110 patients with untreated MS were recruited and studied from June 1, 1997, through June 30, 2003. MAIN OUTCOME MEASURES Cube-rooted CWM-LL and EDSS-measured clinical disability scores. RESULTS We found a large, nonplateauing relationship between cube-rooted CWM-LL and concurrent EDSS scores, more so for T1-hypointense than T2-hyperintense lesions (r = 0.619 vs 0.548). Correlations between the EDSS scores and CWM-LL diminished when, as typically done in clinical trials, only those patients with EDSS scores of 0 to 6.0 were studied (n = 92; r = 0.523 for T1-hypointense lesions and r = 0.457 for T2-hyperintense lesions); more important, a series of boot-strapped correlations suggested that this decrease was not simply due to smaller sample size, and these relationships remained even after correcting for disease duration. CONCLUSION A large, nonplateauing relationship exists between CWM-LL and EDSS-measured clinical disability when patients with MS are studied to examine the entire range of disability, minimize nonbiological sources of variability, and increase pathologic specificity.

[1]  R. Bakshi,et al.  Measurement of Brain and Spinal Cord Atrophy by Magnetic Resonance Imaging as a Tool to Monitor Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[2]  J A Frank,et al.  MRI T2 lesion burden in multiple sclerosis , 2006, Neurology.

[3]  J. Kurtzke Natural history and clinical outcome measures for multiple sclerosis studies.¶Why at the present time does EDSS scale remain a preferred outcome measure to evaluate disease evolution? , 2000, Neurological Sciences.

[4]  D. Arnold,et al.  The role of MRS and fMRI in multiple sclerosis. , 2006, Advances in neurology.

[5]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[6]  F Barkhof,et al.  T1 hypointensities and axonal loss. , 2000, Neuroimaging clinics of North America.

[7]  G. Barker,et al.  Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. , 1996, Magnetic resonance imaging.

[8]  J. Hobart,et al.  Kurtzke scales revisited: the application of psychometric methods to clinical intuition. , 2000, Brain : a journal of neurology.

[9]  D. Collins,et al.  Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach Space , 1994, Journal of computer assisted tomography.

[10]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[11]  Jacob Cohen Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[12]  Zografos Caramanos,et al.  Magnetization transfer can predict clinical evolution in patients with multiple sclerosis , 2002, Journal of Neurology.

[13]  B. Sharrack,et al.  The psychometric properties of clinical rating scales used in multiple sclerosis. , 1999, Brain : a journal of neurology.

[14]  G Cutter,et al.  The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trials , 2002, Multiple sclerosis.

[15]  M Filippi,et al.  Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis. , 2009, Progress in brain research.

[16]  Marco Battaglini,et al.  Brain atrophy assessment in multiple sclerosis: importance and limitations. , 2008, Neuroimaging clinics of North America.

[17]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[18]  Robert Zivadinov,et al.  Clinical–Magnetic Resonance Imaging Correlations in Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[19]  S. Reingold,et al.  The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment , 1999, Multiple sclerosis.

[20]  D. Arnold Evidence for neuroprotection and remyelination using imaging techniques , 2007, Neurology.

[21]  Leland Wilkinson,et al.  Desktop Data Analysis SYSTAT , 1996 .

[22]  Marco Rovaris,et al.  Diffusion tensor MR imaging. , 2009, Neuroimaging clinics of North America.

[23]  Alan C. Evans,et al.  Improved correlation between scores on the expanded disability status scale and cerebral lesion load in relapsing-remitting multiple sclerosis. Results of the application of new imaging methods. , 1998, Brain : a journal of neurology.

[24]  D. Goodin Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: Have we been overly harsh in our assessment? , 2006, Annals of neurology.

[25]  Douglas L Arnold,et al.  Automated quality control of brain MR images , 2008, Journal of magnetic resonance imaging : JMRI.

[26]  A. Thompson,et al.  Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. , 2008, Brain : a journal of neurology.

[27]  Frederik Barkhof,et al.  MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS) , 1999, Multiple sclerosis.

[28]  Alan C. Evans,et al.  Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis , 2002, IEEE Transactions on Medical Imaging.

[29]  P. Lachenbruch Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[30]  A J Thompson,et al.  Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. , 1999, Neurology.

[31]  M. Rovaris,et al.  Contrast enhancement and the acute lesion in multiple sclerosis. , 2000, Neuroimaging clinics of North America.

[32]  S. Ropele,et al.  Magnetization transfer MR imaging in multiple sclerosis. , 2009, Neuroimaging clinics of North America.

[33]  B. Trapp,et al.  Neuropathobiology of multiple sclerosis. , 2005, Neurologic clinics.

[34]  M. Rovaris,et al.  A reassessment of the plateauing relationship between T2 lesion load and disability in MS , 2009, Neurology.

[35]  D. Li,et al.  T2 hyperintensities: findings and significance. , 2000, Neuroimaging clinics of North America.

[36]  Zografos Caramanos,et al.  1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review. , 2005, Brain : a journal of neurology.

[37]  M. Wirtz,et al.  Disability status and quality of life in multiple sclerosis: non-linearity of the Expanded Disability Status Scale (EDSS) , 2010, Health and quality of life outcomes.

[38]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.